The document analyzes the marketing strategy for Enervon-E, a vitamin E supplement aimed at young professionals. It identifies the target market as mid-20s to early-30s professionals prone to lifestyles exposing them to cardiovascular risk. Competitors include Myra-E and vitamins from Solgar and GNC. Enervon-E positions itself as a preventative measure for heart disease. The marketing mix involves print ads, a mid-range price of $12 per capsule, and distribution in drugstores. The strategy focuses on this niche market while leveraging the brand recognition of other Enervon products.